Matching Items (6)
Filtering by

Clear all filters

151860-Thumbnail Image.png
Description
Cancer is the second leading cause of death in the United States and novel methods of treating advanced malignancies are of high importance. Of these deaths, prostate cancer and breast cancer are the second most fatal carcinomas in men and women respectively, while pancreatic cancer is the fourth most fatal

Cancer is the second leading cause of death in the United States and novel methods of treating advanced malignancies are of high importance. Of these deaths, prostate cancer and breast cancer are the second most fatal carcinomas in men and women respectively, while pancreatic cancer is the fourth most fatal in both men and women. Developing new drugs for the treatment of cancer is both a slow and expensive process. It is estimated that it takes an average of 15 years and an expense of $800 million to bring a single new drug to the market. However, it is also estimated that nearly 40% of that cost could be avoided by finding alternative uses for drugs that have already been approved by the Food and Drug Administration (FDA). The research presented in this document describes the testing, identification, and mechanistic evaluation of novel methods for treating many human carcinomas using drugs previously approved by the FDA. A tissue culture plate-based screening of FDA approved drugs will identify compounds that can be used in combination with the protein TRAIL to induce apoptosis selectively in cancer cells. Identified leads will next be optimized using high-throughput microfluidic devices to determine the most effective treatment conditions. Finally, a rigorous mechanistic analysis will be conducted to understand how the FDA-approved drug mitoxantrone, sensitizes cancer cells to TRAIL-mediated apoptosis.
ContributorsTaylor, David (Author) / Rege, Kaushal (Thesis advisor) / Jayaraman, Arul (Committee member) / Nielsen, David (Committee member) / Kodibagkar, Vikram (Committee member) / Dai, Lenore (Committee member) / Arizona State University (Publisher)
Created2013
135853-Thumbnail Image.png
Description
The longstanding issue of how much time it takes a particle to tunnel through quantum barriers is discussed; in particular, the phenomenon known as the Hartman effect is reviewed. A calculation of the dwell time for two successive rectangular barriers in the opaque limit is given and the result depends

The longstanding issue of how much time it takes a particle to tunnel through quantum barriers is discussed; in particular, the phenomenon known as the Hartman effect is reviewed. A calculation of the dwell time for two successive rectangular barriers in the opaque limit is given and the result depends on the barrier widths and hence does not lead to superluminal tunneling or the Hartman effect.
ContributorsMcDonald, Scott (Author) / Davies, Paul (Thesis director) / Comfort, Joseph (Committee member) / McCartney, M. R. (Committee member) / Barrett, The Honors College (Contributor)
Created2009-05
154866-Thumbnail Image.png
Description
Chapter 1 introduces some key elements of important topics such as; quantum mechanics,

representation theory of the Lorentz and Poincare groups, and a review of some basic rela- ´

tivistic wave equations that will play an important role in the work to follow. In Chapter 2,

a complex covariant form of the classical

Chapter 1 introduces some key elements of important topics such as; quantum mechanics,

representation theory of the Lorentz and Poincare groups, and a review of some basic rela- ´

tivistic wave equations that will play an important role in the work to follow. In Chapter 2,

a complex covariant form of the classical Maxwell’s equations in a moving medium or at

rest is introduced. In addition, a compact, Lorentz invariant, form of the energy-momentum

tensor is derived. In chapter 3, the concept of photon helicity is critically analyzed and its

connection with the Pauli-Lubanski vector from the viewpoint of the complex electromag- ´

netic field, E+ iH. To this end, a complex covariant form of Maxwell’s equations is used.

Chapter 4 analyzes basic relativistic wave equations for the classical fields, such as Dirac’s

equation, Weyl’s two-component equation for massless neutrinos and the Proca, Maxwell

and Fierz-Pauli equations, from the viewpoint of the Pauli-Lubanski vector and the Casimir ´

operators of the Poincare group. A connection between the spin of a particle/field and ´

consistency of the corresponding overdetermined system is emphasized in the massless

case. Chapter 5 focuses on the so-called generalized quantum harmonic oscillator, which

is a Schrodinger equation with a time-varying quadratic Hamiltonian operator. The time ¨

evolution of exact wave functions of the generalized harmonic oscillators is determined

in terms of the solutions of certain Ermakov and Riccati-type systems. In addition, it is

shown that the classical Arnold transform is naturally connected with Ehrenfest’s theorem

for generalized harmonic oscillators. In Chapter 6, as an example of the usefulness of the

methods introduced in Chapter 5 a model for the quantization of an electromagnetic field

in a variable media is analyzed. The concept of quantization of an electromagnetic field

in factorizable media is discussed via the Caldirola-Kanai Hamiltonian. A single mode

of radiation for this model is used to find time-dependent photon amplitudes in relation

to Fock states. A multi-parameter family of the squeezed states, photon statistics, and the

uncertainty relation, are explicitly given in terms of the Ermakov-type system.
ContributorsLanfear, Nathan A (Author) / Suslov, Sergei (Thesis advisor) / Kotschwar, Brett (Thesis advisor) / Platte, Rodrigo (Committee member) / Matyushov, Dmitry (Committee member) / Kuiper, Hendrik (Committee member) / Gardner, Carl (Committee member) / Arizona State University (Publisher)
Created2016
154838-Thumbnail Image.png
Description
Cancer is a major health problem in the world today and is expected to become an even larger one in the future. Although cancer therapy has improved for many cancers in the last several decades, there is much room for further improvement. Mathematical modeling has the advantage of being able

Cancer is a major health problem in the world today and is expected to become an even larger one in the future. Although cancer therapy has improved for many cancers in the last several decades, there is much room for further improvement. Mathematical modeling has the advantage of being able to test many theoretical therapies without having to perform clinical trials and experiments. Mathematical oncology will continue to be an important tool in the future regarding cancer therapies and management.

This dissertation is structured as a growing tumor. Chapters 2 and 3 consider spheroid models. These models are adept at describing 'early-time' tumors, before the tumor needs to co-opt blood vessels to continue sustained growth. I consider two partial differential equation (PDE) models for spheroid growth of glioblastoma. I compare these models to in vitro experimental data for glioblastoma tumor cell lines and other proposed models. Further, I investigate the conditions under which traveling wave solutions exist and confirm numerically.

As a tumor grows, it can no longer be approximated by a spheroid, and it becomes necessary to use in vivo data and more sophisticated modeling to model the growth and diffusion. In Chapter 4, I explore experimental data and computational models for describing growth and diffusion of glioblastoma in murine brains. I discuss not only how the data was obtained, but how the 3D brain geometry is created from Magnetic Resonance (MR) images. A 3D finite-difference code is used to model tumor growth using a basic reaction-diffusion equation. I formulate and test hypotheses as to why there are large differences between the final tumor sizes between the mice.

Once a tumor has reached a detectable size, it is diagnosed, and treatment begins. Chapter 5 considers modeling the treatment of prostate cancer. I consider a joint model with hormonal therapy as well as immunotherapy. I consider a timing study to determine whether changing the vaccine timing has any effect on the outcome of the patient. In addition, I perform basic analysis on the six-dimensional ordinary differential equation (ODE). I also consider the limiting case, and perform a full global analysis.
ContributorsRutter, Erica Marie (Author) / Kuang, Yang (Thesis advisor) / Kostelich, Eric J (Thesis advisor) / Frakes, David (Committee member) / Gardner, Carl (Committee member) / Jackiewicz, Zdzislaw (Committee member) / Arizona State University (Publisher)
Created2016
148333-Thumbnail Image.png
Description

This thesis attempts to explain Everettian quantum mechanics from the ground up, such that those with little to no experience in quantum physics can understand it. First, we introduce the history of quantum theory, and some concepts that make up the framework of quantum physics. Through these concepts, we reveal

This thesis attempts to explain Everettian quantum mechanics from the ground up, such that those with little to no experience in quantum physics can understand it. First, we introduce the history of quantum theory, and some concepts that make up the framework of quantum physics. Through these concepts, we reveal why interpretations are necessary to map the quantum world onto our classical world. We then introduce the Copenhagen interpretation, and how many-worlds differs from it. From there, we dive into the concepts of entanglement and decoherence, explaining how worlds branch in an Everettian universe, and how an Everettian universe can appear as our classical observed world. From there, we attempt to answer common questions about many-worlds and discuss whether there are philosophical ramifications to believing such a theory. Finally, we look at whether the many-worlds interpretation can be proven, and why one might choose to believe it.

ContributorsSecrest, Micah (Author) / Foy, Joseph (Thesis director) / Hines, Taylor (Committee member) / Computer Science and Engineering Program (Contributor) / Barrett, The Honors College (Contributor)
Created2021-05
165106-Thumbnail Image.png
Description
Glioblastoma brain tumors are among the most lethal human cancers. Treatment efforts typically involve both surgical tumor removal, as well as ongoing therapy. In this work, we propose the use of deuterium magnetic resonance imaging (MRI) to delineate tumor boundaries based on spatial distributions of deuterated leucine, as well as

Glioblastoma brain tumors are among the most lethal human cancers. Treatment efforts typically involve both surgical tumor removal, as well as ongoing therapy. In this work, we propose the use of deuterium magnetic resonance imaging (MRI) to delineate tumor boundaries based on spatial distributions of deuterated leucine, as well as resolve the metabolism of leucine within the tumor. Accurate boundary identification contributes to effectiveness of tumor removal efforts, while amino acid metabolism information may help characterize tumor malignancy and guide ongoing treatment. So, we first examine the fundamental mechanisms of deuterium MRI. We then discuss the use of spin-echo and gradient recall echo sequences for mapping spatial distributions of deuterated leucine, and the use of single-voxel spectroscopy for imaging metabolites within a tumor.
ContributorsCostelle, Anna (Author) / Beeman, Scott (Thesis director) / Kodibagkar, Vikram (Committee member) / Barrett, The Honors College (Contributor) / Department of Physics (Contributor) / School of Mathematical and Statistical Sciences (Contributor)
Created2022-05